Jagsonpal Pharmaceuticals Limited (NSE:JAGSNPHARM)
India · Delayed Price · Currency is INR 184.69
+0.34 (0.18%)
At close: Mar 27, 2026
Jagsonpal Pharmaceuticals Market Cap
Jagsonpal Pharmaceuticals has a market cap or net worth of 12.37 billion as of March 27, 2026. Its market cap has decreased by -14.15% in one year.
Market Cap
12.37B
Enterprise Value
10.86B
Revenue
2.82B
Ranking
n/a
PE Ratio
30.45
Stock Price
184.69
Market Cap Chart
Since March 1, 2000, Jagsonpal Pharmaceuticals's market cap has decreased from 17.63B to 12.37B, a decrease of -29.86%. That is a compound annual growth rate of -1.35%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Mar 27, 2026 | 12.37B | -3.85% |
| Dec 31, 2025 | 12.86B | -20.68% |
| Dec 31, 2024 | 16.22B | 58.61% |
| Dec 29, 2023 | 10.22B | 4.69% |
| Dec 30, 2022 | 9.77B | 108.36% |
| Dec 31, 2021 | 4.69B | 150.03% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Sun Pharma Advanced Research Company | 39.23B |
| Innova Captab | 38.42B |
| RPG Life Sciences | 30.84B |
| Orchid Pharma | 25.48B |
| Solara Active Pharma Sciences | 21.33B |
| Windlas Biotech | 16.12B |
| Indoco Remedies | 16.01B |
| Ind-Swift Laboratories | 11.98B |